Skip to main content

Sources last read

GLP-1 patches

Ozempic patch: what Novo Nordisk actually makes

There is no FDA-approved Ozempic patch. Ozempic comes as an injection and as tablets, with separate labels and doses. A product sold online as an “Ozempic patch” is not one of those approved medicines.

Source for this answer

Source: Product forms checked against prescribing labels on September 13, 2026

Source: Product forms checked against prescribing labels on September 13, 2026

What matters first

Ozempic patch
No FDA-approved product
Approved forms
Injection and tablets
Same dose?
No — each form has its own label
Manufacturer
Novo Nordisk

The brand name alone does not tell you what is inside a patch or how much reaches the blood. Check the exact product and its form. An approved tablet or injection does not establish that a patch containing the same ingredient works.

Approved injections and tablets

These 9 brands include both injections and tablets. Ozempic and Wegovy each have a separate tablet form. The label link in each row identifies the product; none of these labels describes a patch.

BrandMoleculeApplicationHow it is takenSource
WegovySemaglutideNDA 215256Subcutaneous injection in the abdomen, thigh or upper armPrescribing label
Wegovy tabletsSemaglutideNDA 218316Tablet, swallowed wholePrescribing label
OzempicSemaglutideNDA 209637Subcutaneous injection in the abdomen, thigh or upper armPrescribing label
Ozempic tabletsSemaglutideNDA 213051Tablet, swallowed wholePrescribing label
ZepboundTirzepatideNDA 217806Subcutaneous injection in the abdomen, thigh or upper armPrescribing label
MounjaroTirzepatideNDA 215866Subcutaneous injection in the abdomen, thigh or upper armPrescribing label
TrulicityDulaglutideBLA 125469Subcutaneous injection in the abdomen, thigh or upper armPrescribing label
VictozaLiraglutideNDA 022341Subcutaneous injection in the abdomen, thigh or upper armPrescribing label
SaxendaLiraglutideNDA 206321Subcutaneous injection in the abdomen, thigh or upper armPrescribing label
FoundayoOrforglipronNDA 220934Tablet, swallowed wholePrescribing label
RybelsusSemaglutideNDA 213051Tablet, swallowed wholePrescribing label

Product forms and labels checked September 13, 2026. Tablet and injection doses are not interchangeable. Brand pages explain the individual schedules.

2Read beyond the approved formsThe real needle-free option and what patch listings are actually selling

The needle-free option that does exist

If you would rather avoid injections, approved GLP-1 tablets exist. Oral semaglutide products include Rybelsus, Ozempic tablets and Wegovy tablets. Foundayo is an oral medicine containing a different ingredient, orforglipron. Their approved uses and doses differ.

Oral semaglutide uses an ingredient that helps it pass through the stomach lining. That does not show that it will pass through skin. Microneedle patches are being studied as a different way to deliver drugs; an early trial is not approval for a patch sold online.

See the pill and injection comparison for differences in the products and their instructions. A prescriber can explain which options fit your care.

So what is an “Ozempic patch” listing selling?

One of two things, and they are not related to each other. Most are stickers carrying plant extracts, usually berberine, sold as supplements. Several of those listings state plainly that the product holds no GLP-1 drug at all. A smaller group describes itself as a microneedle patch and says it contains semaglutide or tirzepatide — 4 of the listings we read make that claim, none publishes an ingredient list, and the FDA has written to a seller of one calling it an unapproved new drug.

These are claims made by sellers, not proof of the contents or of drug delivery. The patch brand register records the listings checked and their dates.

Searches for a “tirzepatide patch” or a “semaglutide patch” land in similar claims. The dated registry searches linked in our microneedle guide found no matching human tirzepatide skin-delivery trial. That search result cannot rule out unpublished work or records missed by the query.

What remains unknown

  • The FDA records cited here do not list an approved GLP-1 patch. They do not describe every product sold online.
  • Labels and approvals can change. Each row links the source for that product; this page is a dated check, not a live FDA feed.
  • A tablet is a different product with its own dose schedule and label. Only a prescriber can decide whether it suits a particular person.
  • This page is about brand names and approved forms. Whether a patch could ever work is a research question, and the microneedle record covers it separately.

Questions people actually ask

Does Novo Nordisk make an Ozempic patch?

The cited labels list Ozempic injections and tablets, with no approved patch. The injection is covered by NDA 209637; the tablets share application NDA 213051 with Rybelsus.

Is there a Mounjaro or Zepbound patch?

Neither brand has an approved patch in the cited FDA records. Mounjaro and Zepbound contain tirzepatide and are injected under the skin. A patch using either name is not the product described by those labels.

How much does an Ozempic patch cost?

There is no approved Ozempic patch with a manufacturer price. A price attached to that name belongs to a different product. For approved Ozempic products, the cost records cover it with the manufacturer terms and their exclusions.

Are the patches sold as Ozempic patches safe?

Their safety is not established by the evidence collected here. A search finding no named side-effect report does not prove safety: a reaction may go unreported or be recorded under another name. A seller’s ingredient claim also does not verify what is in the product.

What can I take instead if I do not want injections?

Approved oral options include semaglutide tablets and Foundayo (orforglipron). They have different labels, doses and approved uses. Ask your prescriber about an oral option before changing a prescribed medicine.

Sources

  1. Results Quality Control Review Criteria · ClinicalTrials.gov, U.S. National Library of Medicine · retrieved 2026-09-13
  2. FDA Adverse Event Reporting System (FAERS) Database · U.S. Food and Drug Administration · retrieved 2026-09-13
  3. Internet Pharmacy Warning Letters · U.S. Food and Drug Administration · retrieved 2026-09-13
  4. Drugs@FDA: FDA-Approved Drugs — queried through the openFDA drug/drugsfda endpoint · U.S. Food and Drug Administration · retrieved 2026-08-12
  5. Drugs@FDA: FDA-Approved Drugs (search interface) · U.S. Food and Drug Administration · retrieved 2026-08-12
  6. WEGOVY (semaglutide) injection and tablet — prescribing information · DailyMed, U.S. National Library of Medicine · retrieved 2026-08-12
  7. MOUNJARO (tirzepatide) injection — prescribing information · DailyMed, U.S. National Library of Medicine · retrieved 2026-08-12
  8. NCT07673900 — A Randomized, Phase 1 Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Epi/Intra-dermally Administered Semaglutide (VX-201) Compared to Subcutaneous Administration · ClinicalTrials.gov, U.S. National Library of Medicine · retrieved 2026-08-12
  9. NCT07539415 — A Phase 1 Clinical Trial to Assess the Safety of DWRX5003 and Relative Bioavailability to DWC202502 and DWC202503 in Healthy Adult Volunteers · ClinicalTrials.gov, U.S. National Library of Medicine · retrieved 2026-08-12
  10. The 500 Dalton rule for the skin penetration of chemical compounds and drugs (Exp Dermatol. 2000;9(3):165-9) · Bos JD, Meinardi MM — via PubMed · retrieved 2026-08-12
  11. Transdermal drug delivery (Nat Biotechnol. 2008;26(11):1261-8) · Prausnitz MR, Langer R — via PubMed · retrieved 2026-08-12
  12. Transdermal “Natural GLP-1” Dietary Supplements Violate Law and Place Patients at Risk (Ann Pharmacother. 2026 Aug) · Annals of Pharmacotherapy — via PubMed · retrieved 2026-08-12
  13. Enhanced Stability and Transdermal Delivery of Semaglutide Using an L-Arginine Based Dissolving Microneedle System (AAPS PharmSciTech. 2026 Jul 2) · AAPS PharmSciTech — via PubMed · retrieved 2026-08-12
  14. 21 U.S.C. § 321 — Definitions (subsection (ff), “dietary supplement”) · United States Code, 2023 Edition — via GovInfo · retrieved 2026-08-12
  15. PubChem Compound Summary — molecular weights of approved transdermal active ingredients · PubChem, U.S. National Library of Medicine · retrieved 2026-08-12
  16. PubChem Compound Summary for CID 76943386 — abaloparatide · PubChem, U.S. National Library of Medicine · retrieved 2026-08-13
  17. PubChem Compound Summary for CID 16133850 — teriparatide · PubChem, U.S. National Library of Medicine · retrieved 2026-08-13
  18. PubChem Compound Summary for CID 16132283 — glucagon · PubChem, U.S. National Library of Medicine · retrieved 2026-08-13
  19. PubChem Compound Summary for CID 56843331 — semaglutide · PubChem, U.S. National Library of Medicine · retrieved 2026-08-13
  20. PubChem Compound Summary for CID 166567236 — tirzepatide · PubChem, U.S. National Library of Medicine · retrieved 2026-08-13
  21. PubChem Compound Summary for CID 60857 — zolmitriptan · PubChem, U.S. National Library of Medicine · retrieved 2026-08-13
  22. NCT04064411 — Efficacy & Safety of Abaloparatide-Solid Microstructured Transdermal System in Postmenopausal Women With Osteoporosis (phase 3, results posted) · ClinicalTrials.gov, U.S. National Library of Medicine · retrieved 2026-08-13
  23. NCT01011556 — A Study for the Transdermal Application of Teriparatide (phase 2, results posted) · ClinicalTrials.gov, U.S. National Library of Medicine · retrieved 2026-08-13
  24. NCT00489918 — Dose Ranging Study, Macroflux Parathyroid Hormone (PTH) in Postmenopausal Women With Osteoporosis (phase 2, results posted) · ClinicalTrials.gov, U.S. National Library of Medicine · retrieved 2026-08-13
  25. NCT02745392 — Safety and Efficacy of ZP-Zolmitriptan Intracutaneous Microneedle Systems for the Acute Treatment of Migraine (phase 2/3, results posted) · ClinicalTrials.gov, U.S. National Library of Medicine · retrieved 2026-08-13
  26. openFDA drug adverse event endpoint — the FDA Adverse Event Reporting System (FAERS) · U.S. Food and Drug Administration · retrieved 2026-08-13
  27. CFSAN Adverse Event Reporting System (CAERS) — where reports about foods, cosmetics and dietary supplements are collected · U.S. Food and Drug Administration · retrieved 2026-08-13
  28. Warning Letter to FormPour, MARCS-CMS 722215 (2026-03-31) — “SMGT-GLT-1 Nano Microneedle Patch” offered as an unapproved new drug · U.S. Food and Drug Administration, Center for Drug Evaluation and Research · retrieved 2026-08-13

How we checked these details

Medically reviewed by Jennifer Montecillo, MD · non-practicing medical reviewer

Reviewed 2026-08-13

Product forms were checked against the linked prescribing labels on September 13, 2026. Patch listings and trial searches retain their own evidence dates. This product-form check does not represent a new clinical review. The wider rules are in the sourcing methodology. If something here has gone stale, tell us at contact@healthspanledger.com.

Where these figures come from

Find the right guide before the detail

No guide is a ranked product list or a substitute for individual medical advice.

How well people handled Ozempic in its own trials

Ozempic and Wegovy are the same drug, and their labels report different numbers.

The letter FDA’s search misses, read from FDA’s published warning letters

0 letters come back when FDA’s own index is searched for the class as this letter spells it.

The GLP-1 microneedle patches page, figure by figure

3 further searches that returned nothing, each one printed so it can be re-run.

Dates, dockets and documents rather than commentary

Nothing is written in the future tense about a date that has already passed.

Browse all 51 compound guides

Find uses, published doses, side effects and approval status.

Questions readers ask

Do Ozempic patches really work?

The cited FDA records do not list an approved Ozempic patch. The evidence collected here does not establish that an adhesive patch works as well as an approved injection or tablet.

Oral semaglutide tablets include an ingredient that helps absorption through the stomach lining. That is a different delivery method from a patch, with its own dose and instructions.

Does Ozempic come in a patch?

The cited labels describe Ozempic injections and Ozempic tablets, not a patch. The tablet has a different application and dose schedule from the injection.

Some patch listings claim to contain a GLP-1 drug. A seller’s claim does not establish the contents, FDA approval or how much drug reaches the blood.

How long does it take to lose 20 pounds on Ozempic?

No cited source states how long it takes to reach a particular weight target. Ozempic is approved for adults with type 2 diabetes, not as a weight-loss product.

Weight-loss trial averages cannot predict a person’s timeline. Results also depend on the product, dose, population and length of follow-up. A result for Wegovy is not a result for an Ozempic patch.

Where can I buy Ozempatch?

The dated listing search used for this guide did not find a readable product listing under that name. That search result is not proof that no seller uses it.

A product name in a search result does not show FDA approval or verified ingredients. The cited FDA records do not list an approved Ozempic patch.